ATE485046T1 - Pharmazeutische zusammensetzung enthaltend cordycepin zur behandlung und prävention von fettleibigkeit - Google Patents

Pharmazeutische zusammensetzung enthaltend cordycepin zur behandlung und prävention von fettleibigkeit

Info

Publication number
ATE485046T1
ATE485046T1 AT07833029T AT07833029T ATE485046T1 AT E485046 T1 ATE485046 T1 AT E485046T1 AT 07833029 T AT07833029 T AT 07833029T AT 07833029 T AT07833029 T AT 07833029T AT E485046 T1 ATE485046 T1 AT E485046T1
Authority
AT
Austria
Prior art keywords
obesity
prevention
treatment
cordycepin
pharmaceutical composition
Prior art date
Application number
AT07833029T
Other languages
English (en)
Inventor
Si Kwan Kim
Sung Won Kim
Su Chan Lee
Il Woung Kim
Original Assignee
Univ Konkuk Ind Coop Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Konkuk Ind Coop Corp filed Critical Univ Konkuk Ind Coop Corp
Application granted granted Critical
Publication of ATE485046T1 publication Critical patent/ATE485046T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT07833029T 2006-09-26 2007-09-21 Pharmazeutische zusammensetzung enthaltend cordycepin zur behandlung und prävention von fettleibigkeit ATE485046T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060093732A KR100799116B1 (ko) 2006-09-26 2006-09-26 코디세핀을 함유하는 비만 치료 및 예방제용 약학 조성물
PCT/KR2007/004668 WO2008038973A1 (en) 2006-09-26 2007-09-21 A pharmaceutical composition comprising cordycepin for the treatment and prevention of obesity

Publications (1)

Publication Number Publication Date
ATE485046T1 true ATE485046T1 (de) 2010-11-15

Family

ID=39219654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07833029T ATE485046T1 (de) 2006-09-26 2007-09-21 Pharmazeutische zusammensetzung enthaltend cordycepin zur behandlung und prävention von fettleibigkeit

Country Status (6)

Country Link
EP (1) EP2077851B1 (de)
JP (1) JP4960458B2 (de)
KR (1) KR100799116B1 (de)
AT (1) ATE485046T1 (de)
DE (1) DE602007010018D1 (de)
WO (1) WO2008038973A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101889707A (zh) * 2010-07-16 2010-11-24 大庆市帅亿生物质技术有限公司 虫草口服液及其制备方法
CN102977172B (zh) * 2011-10-26 2015-12-09 中国科学院沈阳应用生态研究所 一种提取虫草素的方法
CN102499435B (zh) * 2011-11-02 2014-01-01 深圳市大百汇技术有限公司 含有虫草花浸膏的卷烟
KR101330044B1 (ko) 2011-11-04 2013-11-15 대한민국 항비만 효과를 갖는 밀리타리스 동충하초 유래 화합물을 포함하는 비만 개선용 약학 조성물
CN103622988B (zh) * 2012-08-23 2016-08-17 北京冠瑞金生物科技有限公司 虫草素在制备抗抑郁症的药物中的用途及其制备而得的快速抗抑郁症药物
JP6220506B2 (ja) * 2012-09-19 2017-10-25 花王株式会社 抑毛剤
KR101963640B1 (ko) 2015-10-30 2019-07-31 심영보 동충하초의 추출방법 및 그 방법에 의해 추출된 추출물
JP2018062477A (ja) * 2016-10-12 2018-04-19 日清食品ホールディングス株式会社 脂肪蓄積抑制剤及びこれを含有する飲食品
KR102665309B1 (ko) * 2016-10-27 2024-05-10 주식회사 엘지생활건강 코디세핀을 포함하는 구강질환 예방 또는 치료용 조성물
JP2017122131A (ja) * 2017-04-17 2017-07-13 花王株式会社 抑毛剤
KR102141862B1 (ko) * 2017-04-25 2020-08-06 부산대학교 산학협력단 밀리타리스 동충하초의 코르디세핀 및 딸기의 기능성 물질 생산량 증대 방법 및 발효 추출물을 포함하는 비만 예방 또는 치료용 조성물
KR101911736B1 (ko) 2018-05-02 2018-10-25 윤영훈 코디세핀-단백질 분해 효소 접합체를 유효성분으로 함유하는 면역활성 증강용 조성물
CN109553647A (zh) * 2018-12-26 2019-04-02 中国科学院西北高原生物研究所 代谢产物的提取方法、添加剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0812588A (ja) * 1994-06-30 1996-01-16 Meiji Milk Prod Co Ltd 組成物
DE69531782T2 (de) 1994-06-30 2004-07-01 Meiji Dairies Corp. Heisswasser-Extrakt von Cordyceps sinensis
JP3990061B2 (ja) * 1998-01-05 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 プリン誘導体および糖尿病の予防・治療剤としてのアデノシンａ２受容体拮抗剤
KR20010017055A (ko) * 1999-08-06 2001-03-05 심규광 동충하초 함유 장류
JP2001131196A (ja) * 1999-11-05 2001-05-15 Mitsubishi Chemicals Corp コルジセピン誘導体の製造方法
KR20010054264A (ko) * 1999-12-04 2001-07-02 안용준 동충하초로부터 분리 추출된 항암제용 코디세핀과 그제조방법
JP4673958B2 (ja) * 2000-06-19 2011-04-20 株式会社日本触媒 固形物除去装置
KR100464876B1 (ko) * 2001-11-15 2005-01-06 학교법인 인제학원 동충하초의 코르디세핀을 함유하는 항혈전제 조성물
KR20040054896A (ko) * 2002-12-18 2004-06-26 이상몽 누에 눈꽃 동충하초 분말을 함유하는 지질대사 개선용조성물
KR100514315B1 (ko) * 2003-01-06 2005-09-13 주식회사 웰스킨 매트릭스 메탈로프로테아제-1을 억제하는 피부노화 방지용 약학 조성물
KR100583194B1 (ko) * 2003-12-22 2006-05-24 이승정 코디세핀을 함유하는 당뇨병의 치료 및 예방용 조성물
CA2573682A1 (en) * 2004-07-12 2006-02-16 Cv Therapeutics, Inc. Process for the preparation of a1 adenosine receptor agonists
CN100509013C (zh) * 2005-09-19 2009-07-08 谭玉杰 一种调理补气溶脂膏

Also Published As

Publication number Publication date
DE602007010018D1 (de) 2010-12-02
WO2008038973A1 (en) 2008-04-03
EP2077851A4 (de) 2009-12-16
JP4960458B2 (ja) 2012-06-27
EP2077851A1 (de) 2009-07-15
EP2077851B1 (de) 2010-10-20
KR100799116B1 (ko) 2008-01-29
JP2010503729A (ja) 2010-02-04

Similar Documents

Publication Publication Date Title
ATE485046T1 (de) Pharmazeutische zusammensetzung enthaltend cordycepin zur behandlung und prävention von fettleibigkeit
Lee Collaborative power of Nrf2 and PPARγ activators against metabolic and drug‐induced oxidative injury
Bandele et al. Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement
Tsai et al. Hepatoprotective effect of electrolyzed reduced water against carbon tetrachloride-induced liver damage in mice
Christina et al. Inhibition of CCl4-induced liver fibrosis by Piper longum Linn.?
Srinivas Recent trends in preclinical drug–drug interaction studies of flavonoids—Review of case studies, issues and perspectives
Asadollahi et al. Hepatoprotective potential of prosopis farcta beans extracts against acetaminophen-induced hepatotoxicity in wister rats
Wang et al. Four different structural dietary polyphenols, especially dihydromyricetin, possess superior protective effect on ethanol-induced ICE-6 and AML-12 cytotoxicity: the role of CYP2E1 and Keap1-Nrf2 pathways
NO20084256L (no) DPP IV inhibitorformuleringer
MX2009010894A (es) Derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de estearoil-coa-desaturasa.
Ganapaty et al. Free radical scavenging activity of gossypin and nevadensin: An: In-vitro: Evaluation
WO2008028965A3 (en) Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof
WO2009152189A8 (en) Low dose topiramate/phentermine compostion and methods of use thereof
WO2009031606A1 (ja) 関節炎治療及び予防剤
Federico et al. Silybin–phosphatidylcholine complex protects human gastric and liver cells from oxidative stress
WO2008112773A3 (en) Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
WO2008042480A3 (en) Epoxide inhibitors of cysteine proteases
WO2009099553A3 (en) Use of kinase inhibitor in treatment of atherosclerosis
Chen et al. Ameliorative effects of D-glucuronolactone on oxidative stress and inflammatory/fibrogenic responses in livers of thioacetamide-treated rats
WO2011044523A3 (en) Compositions and methods for treating obesity
WO2009091120A3 (en) Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases
WO2006085115A3 (en) Therapeutic uses of tomato extracts
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
Duh et al. Hepatoprotection of Graptopetalum paraguayense E. Walther on CCl4-induced liver damage and inflammation
Kojima-Yuasa Biological and pharmacological effects of polyphenolic compounds from Ecklonia cava

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties